🇺🇸 Sialanar in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 2 reports (18.18%)
  2. Depressed Level Of Consciousness — 1 report (9.09%)
  3. Device Dislocation — 1 report (9.09%)
  4. Fall — 1 report (9.09%)
  5. Hip Fracture — 1 report (9.09%)
  6. Hypertriglyceridaemia — 1 report (9.09%)
  7. Hypothyroidism — 1 report (9.09%)
  8. Increased Bronchial Secretion — 1 report (9.09%)
  9. Parkinson^S Disease — 1 report (9.09%)
  10. Pneumonia — 1 report (9.09%)

Source database →

Sialanar in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in United States

Frequently asked questions

Is Sialanar approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Sialanar in United States?

Proveca Pharma Limited is the originator. The local marketing authorisation holder may differ — check the official source linked above.